| 1 | varied | 5,164 |
| 2 | varies | 1,412 |
| 3 | differs | 906 |
| 4 | overlapped | 133 |
| 5 | deviates | 35 |
| 6 | fluctuates | 21 |
| 7 | alternates | 9 |
| 8 | swelled | 4 |
| 9 | 2,8-dihydroxy-1,6-dimethoxyxanthone | 3 |
| 10 | asso- | 2 |
| 11 | cog0613 | 2 |
| 12 | ethno-medically | 2 |
| 13 | 1,1.5 | 1 |
| 14 | 1,5,50 | 1 |
| 15 | 1.23ng/ml | 1 |
| 16 | 20/0.02 | 1 |
| 17 | 25/.04 | 1 |
| 18 | 29-items | 1 |
| 19 | 50/05 | 1 |
| 20 | 7.4years | 1 |
| 21 | a-b-c | 1 |
| 22 | aminobenzylpenicillin | 1 |
| 23 | area-varied | 1 |
| 24 | condes | 1 |
| 25 | cyclo-diphosphadiazanes | 1 |
| 26 | delocalise | 1 |
| 27 | eight-winds | 1 |
| 28 | emergence-a | 1 |
| 29 | experience/familiarity | 1 |
| 30 | factors-can | 1 |
| 31 | fluvastain | 1 |
| 32 | fmri-techniques | 1 |
| 33 | iemp | 1 |
| 34 | lys133 | 1 |
| 35 | maintenance-is | 1 |
| 36 | msn2/4p | 1 |
| 37 | oftao | 1 |
| 38 | planktonicum | 1 |
| 39 | pro/antitumoral | 1 |
| 40 | qp/qm | 1 |
| 41 | rekicen- | 1 |
| 42 | self-disliked | 1 |
| 43 | self-medications | 1 |
| 44 | ssris-are | 1 |
| 45 | steepens | 1 |
| 46 | st£108.12 | 1 |
| 47 | t2fs | 1 |
| 48 | β2i | 1 |
| 1 | 1,1.5 | 1 |
| 2 | 1,5,50 | 1 |
| 3 | 1.23ng/ml | 1 |
| 4 | 2,8-dihydroxy-1,6-dimethoxyxanthone | 3 |
| 5 | 20/0.02 | 1 |
| 6 | 25/.04 | 1 |
| 7 | 29-items | 1 |
| 8 | 50/05 | 1 |
| 9 | 7.4years | 1 |
| 10 | a-b-c | 1 |
| 11 | alternates | 9 |
| 12 | aminobenzylpenicillin | 1 |
| 13 | area-varied | 1 |
| 14 | asso- | 2 |
| 15 | cog0613 | 2 |
| 16 | condes | 1 |
| 17 | cyclo-diphosphadiazanes | 1 |
| 18 | delocalise | 1 |
| 19 | deviates | 35 |
| 20 | differs | 906 |
| 21 | eight-winds | 1 |
| 22 | emergence-a | 1 |
| 23 | ethno-medically | 2 |
| 24 | experience/familiarity | 1 |
| 25 | factors-can | 1 |
| 26 | fluctuates | 21 |
| 27 | fluvastain | 1 |
| 28 | fmri-techniques | 1 |
| 29 | iemp | 1 |
| 30 | lys133 | 1 |
| 31 | maintenance-is | 1 |
| 32 | msn2/4p | 1 |
| 33 | oftao | 1 |
| 34 | overlapped | 133 |
| 35 | planktonicum | 1 |
| 36 | pro/antitumoral | 1 |
| 37 | qp/qm | 1 |
| 38 | rekicen- | 1 |
| 39 | self-disliked | 1 |
| 40 | self-medications | 1 |
| 41 | ssris-are | 1 |
| 42 | steepens | 1 |
| 43 | st£108.12 | 1 |
| 44 | swelled | 4 |
| 45 | t2fs | 1 |
| 46 | varied | 5,164 |
| 47 | varies | 1,412 |
| 48 | β2i | 1 |
| 1 | rekicen- | 1 |
| 2 | asso- | 2 |
| 3 | 1,5,50 | 1 |
| 4 | 20/0.02 | 1 |
| 5 | st£108.12 | 1 |
| 6 | cog0613 | 2 |
| 7 | lys133 | 1 |
| 8 | 25/.04 | 1 |
| 9 | 1,1.5 | 1 |
| 10 | 50/05 | 1 |
| 11 | emergence-a | 1 |
| 12 | a-b-c | 1 |
| 13 | varied | 5,164 |
| 14 | area-varied | 1 |
| 15 | self-disliked | 1 |
| 16 | swelled | 4 |
| 17 | overlapped | 133 |
| 18 | 2,8-dihydroxy-1,6-dimethoxyxanthone | 3 |
| 19 | ssris-are | 1 |
| 20 | delocalise | 1 |
| 21 | β2i | 1 |
| 22 | pro/antitumoral | 1 |
| 23 | 1.23ng/ml | 1 |
| 24 | qp/qm | 1 |
| 25 | planktonicum | 1 |
| 26 | factors-can | 1 |
| 27 | fluvastain | 1 |
| 28 | aminobenzylpenicillin | 1 |
| 29 | oftao | 1 |
| 30 | msn2/4p | 1 |
| 31 | iemp | 1 |
| 32 | eight-winds | 1 |
| 33 | condes | 1 |
| 34 | varies | 1,412 |
| 35 | cyclo-diphosphadiazanes | 1 |
| 36 | deviates | 35 |
| 37 | alternates | 9 |
| 38 | fluctuates | 21 |
| 39 | fmri-techniques | 1 |
| 40 | t2fs | 1 |
| 41 | maintenance-is | 1 |
| 42 | 29-items | 1 |
| 43 | steepens | 1 |
| 44 | self-medications | 1 |
| 45 | 7.4years | 1 |
| 46 | differs | 906 |
| 47 | ethno-medically | 2 |
| 48 | experience/familiarity | 1 |